Buzzing Stocks: John Cockerill up 7% on order win; Bliss GVS hits 52-week high on inspection closure report

About this update from Bliss Gvs Pharma Limited

Several stocks remained in focus on June 3 as corporate developments, earnings announcements, and regulatory triggers continued to drive market activity.John Cockerill India gained 7 percent, hitting 52-week high, after the company secured an order worth Rs 1,250-1,300 crore from JSW Vijayanagar Metallics for a Cold Rolled Non-Oriented (CRNO) electrical steel project.Advait Energy Transitions rose 2 percent after its subsidiary, Advait BESS Bhesaan, signed a Battery Energy Storage Purchase Agreement (BESPA) with Gujarat Urja Vikas Nigam Ltd (GUVNL). The agreement is for the development of a standalone Battery Energy Storage System (BESS) project with a capacity of 150 MW/300 MWh.Bliss GVS Pharma shares hit 52-week high after its Palghar-based manufacturing facility received an Inspection Closure Report from the World Health Organization (WHO), confirming compliance with WHO Good Manufacturing Practices (GMP) standards.Concord Biotech advanced 4 percent after receiving approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. The drug is used as an immunosuppressant to help prevent organ rejection in kidney, heart, and liver transplant recipients.Market participants said that news flow remains a key driver in the current market environment, with investors closely monitoring corporate announcements and sector-specific developments. As the earnings season progresses, company-specific updates are expected to continue driving stock-specific volatility.

View stock analysis, news, and events for Bliss Gvs Pharma Limited